A randomized clinical trial conducted in India has demonstrated that incorporating yoga into standard care for opioid use disorder (OUD) can significantly accelerate the recovery process from opioid withdrawal. The study, published in JAMA Psychiatry, found that male patients who received buprenorphine treatment along with 10 supervised yoga classes recovered from withdrawal symptoms approximately four days faster than those who received buprenorphine alone. Specifically, the median time to stabilization of withdrawal symptoms was reduced from nine days to five days in the yoga group. The findings suggest that yoga acts as a neurobiologically informed intervention, addressing core regulatory processes beyond mere symptom management. Researchers observed that yoga improved autonomic nervous system regulation, as evidenced by significant improvements in heart rate variability (HRV). Furthermore, participants in the yoga group reported significant reductions in anxiety scores and moderate benefits in terms of sleep onset latency and pain levels. The study suggests that yoga's benefits may be partly attributed to its ability to restore parasympathetic activity, counteracting the sympathetic hyperarousal characteristic of opioid withdrawal. While acknowledging limitations such as a male-only sample and a short intervention period, the researchers advocate for the integration of yoga into withdrawal protocols, highlighting its potential as a low-cost, low-risk adjunctive therapy that can enhance treatment retention and support long-term recovery from opioid addiction. The research was supported by the DBT/Wellcome Trust India Alliance Fellowship.